We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+16.02%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$3.09B
AUM Growth
+$972M
Cap. Flow
+$684M
Cap. Flow %
22.14%
Top 10 Hldgs %
6.41%
Holding
2,561
New
545
Increased
906
Reduced
750
Closed
342

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$27.9M
2
HUM icon
Humana
HUM
+$18.6M
3
CMS icon
CMS Energy
CMS
+$17.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$15M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.5M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$92M
2
MSFT icon
Microsoft
MSFT
+$10.4M
3
RTX icon
RTX Corp
RTX
+$10.3M
4
SNPS icon
Synopsys
SNPS
+$10.3M
5
WY icon
Weyerhaeuser
WY
+$9.46M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.11%
2 Technology 15.39%
3 Healthcare 12.56%
4 Financials 10.75%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTEX icon
2376
Open Text
OTEX
$6.23B
-15,785
Closed -$515K
PATK icon
2377
Patrick Industries
PATK
$2.87B
-58,157
Closed -$1.15M
PCG icon
2378
PG&E
PCG
$37.4B
-59,762
Closed -$1.42M
PCTY icon
2379
Paylocity
PCTY
$8.39B
-3,476
Closed -$209K
PEGA icon
2380
Pegasystems
PEGA
$5.21B
-2,758
Closed -$66K
PETS icon
2381
PetMed Express
PETS
$42.1M
-14,715
Closed -$342K
PG icon
2382
Procter & Gamble
PG
$342B
-7,595
Closed -$698K
PHG icon
2383
Philips
PHG
$25.7B
-27,025
Closed -$737K
PLAB icon
2384
Photronics
PLAB
$1.88B
-13,913
Closed -$135K
PLXS icon
2385
Plexus
PLXS
$7.18B
-23,171
Closed -$1.18M
PNFP icon
2386
Pinnacle Financial Partners Inc
PNFP
$16.1B
-2,639
Closed -$122K
PPBI
2387
DELISTED
Pacific Premier Bancorp
PPBI
-14,738
Closed -$376K
PSEC icon
2388
Prospect Capital
PSEC
$1.11B
-23,539
Closed -$149K
P
2389
Everpure Inc
P
$29B
-155,030
Closed -$2.49M
QMCO icon
2390
Quantum Corp
QMCO
$460M
-2,769
Closed -$111K
RARE icon
2391
Ultragenyx Pharmaceutical
RARE
$2.54B
-19,929
Closed -$867K
RDNT icon
2392
RadNet
RDNT
$5.36B
-14,477
Closed -$147K
RDY icon
2393
Dr. Reddy's Laboratories
RDY
$10.1B
-1,280
Closed -$10K
RGNX icon
2394
Regenxbio
RGNX
$722M
-10,844
Closed -$455K
RITM icon
2395
Rithm Capital
RITM
$5.55B
-9,360
Closed -$133K
RMD icon
2396
ResMed
RMD
$32.4B
-10,400
Closed -$1.18M
SAP icon
2397
SAP
SAP
$230B
-3,594
Closed -$358K
SBLK icon
2398
Star Bulk Carriers
SBLK
$3.19B
-27,638
Closed -$253K
SCCO icon
2399
Southern Copper
SCCO
$161B
-15,595
Closed -$445K
SFL icon
2400
SFL Corp
SFL
$1.61B
-17,738
Closed -$187K

Similar funds

Cubist Systematic Strategies's Q1 2019 Portfolio in Review

As of Q1 2019, Cubist Systematic Strategies held 2,561 positions worth $3.09B, up 46% from $2.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Cubist Systematic Strategies deployed $684M of net new capital in Q1 2019, opening 545 new positions and adding to 906 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92M trimmed.

  • Cubist Systematic Strategies's largest Q1 2019 buy was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
  • Cubist Systematic Strategies added most to ConocoPhillips in Q1 2019, an estimated $27.9M increase.
  • Cubist Systematic Strategies's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92M.
  • Cubist Systematic Strategies fully exited Nasdaq in Q1 2019, selling an estimated $6.35M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.4% of its $3.09B portfolio in Q1 2019.
  • Cubist Systematic Strategies opened 545 new positions and closed 342 in Q1 2019.
  • Cubist Systematic Strategies's portfolio value rose 46% quarter-over-quarter to $3.09B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.